On October 3, 2018, Juul Labs, Inc. of San Francisco, California (“JLI”) filed a complaint (part 1 and part 2) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that the following entities (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain electronic nicotine delivery systems and components thereof that infringe one or more claims of U.S. Patent Nos. 10,070,669 (the ’669 patent), 10,076,139 (the ’139 patent), 10,045,568 (the ’568 patent), and 10,058,130 (the ’130 patent) (collectively, the “asserted patents”):

Read More

On September 14, 2018, INVT SPE LLC of San Francisco, California (“INVT”) filed a complaint (part 1 and part 2) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that Apple Inc. of Cupertino, California (“Apple”), HTC Corp. of Taiwan and HTC America, Inc. of Seattle, Washington (collectively, “HTC”), and ZTE Corp. of China and ZTE (USA) Inc. of Richardson, Texas (collectively, “ZTE”) (all collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain LTE- and 3G-compliant cellular communications devices that infringe one or more claims of U.S. Patent Nos. 6,760,590 (the ’590 patent), 7,206,587 (the ’587 patent), 7,764,711 (the ’711 patent), 7,848,439 (the ’439 patent), and 7,339,949 (the ’949 patent) (collectively, the “asserted patents”).

Read More

On September 12, 2018, ASML Netherlands B.V. of the Netherlands, ASML US, L.P. of Chandler, Arizona, and ASML US, LLC of Chandler, Arizona (collectively, “ASML”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that Nikon Corp. of Japan, Nikon Precision Inc. of Belmont, California, and Nikon Research Corp. of America of Belmont, California (collectively, “Nikon”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain semiconductor lithography systems and components thereof that infringe one or more claims of U.S. Patent Nos. 7,295,283 (the ’283 patent), 7,403,264 (the ’264 patent), and 9,188,880 (the ’880 patent) (collectively, the “asserted patents”).

Read More

On September 10, 2018, Fisher & Paykel Healthcare Ltd. of New Zealand (“FPH”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that ResMed Corp. of San Diego, California, ResMed Inc. of San Diego, California, and ResMed Ltd. of Australia (collectively, “ResMed”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain obstructive sleep apnea treatment systems and components thereof that infringe one or more claims of U.S. Patent Nos. 9,333,315 (the ’315 patent), 9,517,317 (the ’317 patent), 9,539,405 (the ’405 patent), 9,907,925 (the ’925 patent), and 9,974,914 (the ’914 patent) (collectively, the “asserted patents”).

Read More

On August 30, 2018, Autel Robotics USA LLC of Bothell, Washington (“Autel”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that SZ DJI Technology Co. Ltd. of China, DJI Europe B.V. of the Netherlands, DJI Technology Inc. of Burbank, California, iFlight Technology Co. Ltd. of Hong Kong, DJI Baiwang Technology Co. Ltd. of China, DJI Research LLC of Palo Alto, California, DJI Service LLC of Cerritos, California, and DJI Creative Studio LLC of Burbank, California (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain unmanned aerial vehicles and components thereof that infringe one or more claims of U.S. Patent Nos. 7,979,174 (“the ’174 patent”), 9,260,184 (“the ’184 patent”), and 10,044,013 (“the ’013 patent”).

Read More

On August 1, 2018, FCA US LLC of Auburn Hills, Michigan (“FCA”) filed a complaint (part 1 and part 2) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that Mahindra & Mahindra Ltd. of India and Mahindra Automotive North America, Inc. of Auburn Hills, Michigan (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain motorized vehicles and components thereof that violate common law trade dress and registered trademarks used with and displayed on Jeep®-brand vehicles manufactured and sold by FCA and its predecessors.

Read More

On June 12, 2018, Walbro, LLC of Tucson Arizona (“Walbro”) filed a complaint (part 1, part 2, part 3, and part 4) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that the following entities (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain carburetors and products containing same that infringe one or more claims of U.S. Patent Nos. 6,394,424 (the ’424 patent), 6,439,547 (the ’547 patent), 6,533,254 (the ’254 patent), 6,540,212 (the ’212 patent), and 7,070,173 (the ’173 patent) (collectively, the “asserted patents”):

Read More

On February 2, 2018, Lumencor, Inc. of Beaverton, Oregon (“Lumencor”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that Excelitas Technologies Corp. of Waltham, Massachusetts and Lumen Dynamics Group, Inc. of Canada (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain light engines and components thereof that infringe one or more claims of U.S. Patent Nos. 9,574,722 (the ’722 patent), 9,395,055 (the ’055 patent), and 8,493,564 (the ’564 patent) (collectively, the “asserted patents”).

Read More

Read More

On January 11, 2018, 10X Genomics, Inc. of Pleasanton, California (“10X Genomics”) filed a complaint (part 1, part 2, and part 3) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that Bio-Rad Laboratories, Inc. of Hercules, California (“Bio-Rad”) unlawfully imports into the U.S., sells for importation, and/or sells within the U.S. after importation certain microfluidic systems, components thereof, and products containing the same that infringe one or more claims of U.S. Patent Nos. 9,644,204 (the ’204 patent), 9,689,024 (the ’024 patent), 9,695,468 (the ’468 patent), and 9,856,530 (the ’530 patent) (collectively, the “asserted patents”).

Read More